company background image
4747 logo

Johnson Chemical Pharmaceutical Works TPEX:4747 Stock Report

Last Price

NT$71.90

Market Cap

NT$3.2b

7D

0.6%

1Y

-13.5%

Updated

08 Jan, 2025

Data

Company Financials

Johnson Chemical Pharmaceutical Works Co., Ltd.

TPEX:4747 Stock Report

Market Cap: NT$3.2b

My Notes

Capture your thoughts, links and company narrative

Johnson Chemical Pharmaceutical Works Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Johnson Chemical Pharmaceutical Works
Historical stock prices
Current Share PriceNT$71.90
52 Week HighNT$91.60
52 Week LowNT$61.20
Beta-0.37
1 Month Change1.27%
3 Month Change3.90%
1 Year Change-13.48%
3 Year Change106.61%
5 Year Change83.65%
Change since IPO227.43%

Recent News & Updates

Recent updates

Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat?

Mar 25
Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat?

These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well

Feb 18
These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well

Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock

Feb 01
Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock

Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)

Jan 12
Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)

Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?

Dec 25
Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?

Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?

Dec 07
Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?

Shareholder Returns

4747TW PharmaceuticalsTW Market
7D0.6%-0.1%1.5%
1Y-13.5%2.1%31.4%

Return vs Industry: 4747 underperformed the TW Pharmaceuticals industry which returned 1.6% over the past year.

Return vs Market: 4747 underperformed the TW Market which returned 32.2% over the past year.

Price Volatility

Is 4747's price volatile compared to industry and market?
4747 volatility
4747 Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement3.6%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.7%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 4747 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4747's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1959170Pai-Hsiung Huangwww.jcpjohnson.com.tw

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms.

Johnson Chemical Pharmaceutical Works Co., Ltd. Fundamentals Summary

How do Johnson Chemical Pharmaceutical Works's earnings and revenue compare to its market cap?
4747 fundamental statistics
Market capNT$3.23b
Earnings (TTM)NT$81.83m
Revenue (TTM)NT$618.33m

39.5x

P/E Ratio

5.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4747 income statement (TTM)
RevenueNT$618.33m
Cost of RevenueNT$371.38m
Gross ProfitNT$246.95m
Other ExpensesNT$165.12m
EarningsNT$81.83m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.82
Gross Margin39.94%
Net Profit Margin13.23%
Debt/Equity Ratio8.9%

How did 4747 perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

82%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 09:24
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Johnson Chemical Pharmaceutical Works Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Regina LeeCapital Securities Corporation